Among proteins relevant to non-CBF, the overexpression of TESC also shown to be highly expressed in FLT3-ITD(+) AML mediating sorafenib resistance [38], suggesting potential drug resistance in non-CBF AML. Here, TESC is linked to acute myeloid leukemia.